N/A
Manufactured by Fresenius Kabi USA, LLC
14,601 FDA adverse event reports analyzed
Last updated: 2026-04-15
PYRIDOXINE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Fresenius Kabi USA, LLC. The most commonly reported adverse reactions for PYRIDOXINE HYDROCHLORIDE include OFF LABEL USE, NAUSEA, VOMITING, PAIN, GENERAL PHYSICAL HEALTH DETERIORATION. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for PYRIDOXINE HYDROCHLORIDE.
Out of 2,440 classified reports for PYRIDOXINE HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 14,601 FDA FAERS reports that mention PYRIDOXINE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include OFF LABEL USE, NAUSEA, VOMITING, PAIN, GENERAL PHYSICAL HEALTH DETERIORATION, ABDOMINAL PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Fresenius Kabi USA, LLC in connection with PYRIDOXINE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.